The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: Biology and clinical significance

British Journal of Haematology

Volumn 106, Issue 2, 1999, Pages 296-308

  Downing, James R ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

AML1; AML1 ETO; Haemopoiesis; Leukaemia; Transcription

Indexed keywords

CHIMERIC PROTEIN; HYBRID PROTEIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION 8; GENE TARGETING; HUMAN; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

ACUTE DISEASE; CHIMERA; CHROMOSOMES, HUMAN, PAIR 21; CHROMOSOMES, HUMAN, PAIR 8; ENHANCER ELEMENTS (GENETICS); HUMANS; LEUKEMIA, MYELOID; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 0032822953     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01377.x     Document Type: Review

References (134)

1. Adya, N., Stacy, T., Speck, N.A. & Liu, P.P. (1998) The leukemic protein core binding factor β (CBFβ)-smooth-muscle myosin heavy chain sequesters CBFα2 into cytoskeletal filaments and aggregates. Molecular and Cellular Biology 18, 7432-7443.
2. Ahn, M.Y., Huang, G., Bae, S.C., Wee, H.J., Kim, W.Y. & Ito, Y. (1998) Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32DcI3 by ear-2, a mammalian, homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO. Proceedings of the National Academy of Sciences of the United States of America, 95, 1812-1817.
3. Andrieu, V., Radford-Weiss, I., Troussard, X., Chane, C., Valensi, F., Guesnu, M., Haddad, E., Viguier, P., Dreyfus, F., Varet, B., Flandrin, G. & Macintyre, E. (1996) Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. British Journal of Haematology, 92, 855-865.
4. Aronson, B.D., Fisher, A.L., Blechman, K., Caudy, M. & Gergen, J.P. (1997) Groucho-dependent and-independent repression activities of Runt domain proteins. Molecular and Cellular Biology, 17, 5581-5587.
5. Bae, S.C., Ogawa, E., Maruyama, M., Oka, H., Satake, M., Shigesada, K., Jenkins, N.A., Gilbert, D.J., Copeland, N.G. & Ito, Y. (1994) PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Molecular and Cellular Biology, 14, 3242-3252.
6. Banker, D.E., Radich, J., Becker, A., Kerkof, K., Norwood, T., Willman, C. & Appelbaum, F.R. (1998) The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults. Clinical Cancer Research, 4, 3051-3062.
7. Bitter, M.A., LeBeau, M.M., Rowley, J.D., Larson, R.A., Golomb, H.M. & Vardiman, J.W. (1987) Associations between morphology, karyotype, and clinical features in myeloid leukemias. Human Pathology 18, 211-225.
8. Bloomfield, C.D., Lawrence, D., Byrd, J.C., Carroll, A., Pettenati, M.J., Tantravahi, R., Patil, S.R., Davey, F.R., Berg, D.T., Schiffer, C.A., Arthur, D.C. & Mayer, R.J. (1998) Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. Cancer Research, 58, 4173-4179.
9. Britos-Bray, M. & Friedman, A.D. (1997) Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb. Molecular and Cellular Biology, 17, 5127-5135.
10. Britos-Bray, M., Ramirez, M., Cao, W., Wang, X., Liu, P.P., Civin, C.I., & Friedman, A.D. (1998) CBFβ-SMMHC, expressed in M4eo acute myeloid leukemia, reduces p53 induction and slows apoptosis in hematopoietic cells exposed to DNA-damaging agents. Blood, 92, 4344-4352.
11. Bruhn, L., Munnerlyn, A. & Grosschedl, R. (1997) ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRα enhancer function. Genes and Development, 11, 640-653.
12. Carey, M. (1998) The enhanceosome and transcriptional synergy. Cell, 92, 5-8.
13. Chen, H., Lin, R.J., Schiltz, R.L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M.L., Nakatani, Y. & Evans, R.M. (1997) Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell, 90, 569-580.
14. Chen, L.-F., Ito, K., Murakami, Y. & Ito, Y. (1998) The capacity of polyomavirus enhancer binding protein 2αB (AML1/Cbfa2) to stimulate polyomavirus DNA replication is related to its affinity for the nuclear matrix. Molecular and Cellular Biology, 18, 4165-4176.
15. Chiba, N., Watanabe, T., Nomura, S., Tanaka, Y., Minowa, M., Niki, M., Kanamaru, R. & Satake, M. (1997) Differentiation dependent expression and distinct subcellular localization of the protooncogene product, PEBP2beta/CBFβ. in muscle development. Oncogene, 14, 2543-2552.
16. Clevers, H. & van de Wetering, M. (1997) TCF/LEF factors earn their wings. Trends in Genetics, 13, 485-489.
17. Collins, S.J. (1998) Acute promyelocytic leukemia: relieving repression induces remission. Blood, 91, 2631-2633.
18. Corsetti, M.T. & Calabi, F. (1997) Lineage-and stage-specific expression of runt box polypeptides in primitive and definitive hematopoiesis. Blood, 89, 2359-2368.
19. Crute, B.E., Lewis, A .F., Wu, Z., Bushweller, J.H. & Speck, N.A. (1996) Biochemical and biophysical properties of the core-binding factor α2 (AML1) DNA-binding domain. Journal of Biological Chemistry, 271, 26251-26260.
20. Daga, A., Karlovich, C.A., Dumstrei, K. & Banerjee, U. (1996) Patterning of cells in the Drosophila eye by Lozenge, which shares homologous domains with AML1. Genes and Development, 10, 1194-1205.
21. Daga, A., Tighe, J.E. & Calabi, F. (1992) Leukemia/Drosophila homology. Nature, 356, 484.
22. DePamphilis, M.L. (1991) Eukaryotic DNA replication: anatomy of an origin. Annual Review of Biochemistry, 62, 29-63.
23. Dormand, E.-L. & Brand, A.H. (1998) Runt determines cell fates in the Drosophila embryonic CNS. Development, 125, 1659-1667.
24. Downing, J.R., Head, D.R., Curcio-Brint, A.M., Hulshof, M.G., Motroni, T.A., Raimondi, S.C., Carroll, A.J., Drabkin, H.A., Willman, C. & Theil, K.S. (1993) An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood, 81, 2860-2865.
25. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A.L. & Karsenty, G. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell, 89, 747-754.
26. Era, T., Asou, N., Kunisada, T., Yamasaki, H., Asou, H., Kamada, N., Nishikawa, S., Yamaguchi. K. & Takatsuki, K. (1995a) Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes. Chromosomes and Cancer, 13, 25-33.
27. Era, T., Asou, N., Yamaguchi, K., Yamasaki, H., Kamada, N., Nishikawa, S. & Takatsuki, K. (1995b) Expression of AML1 and ETO transcripts in hematopoietic cells. Leukemia, 9, (Suppl. 1), S26-S28.
28. Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J. & Drabkin, H. (1992) Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript. AML1/ETO, wild similarity to Drosophila segmentation gene, runt. Blood, 80, 1825-1831.
29. Erman, B., Cortes, M., Nikolajczyk, B.S., Speck, N.A. & Sen, R. (1998) ETS-core binding factor: a common composite motif in antigen receptor gene enhancers. Molecular and Cellular Biology, 18, 1322-1330.
30. Feinstein, P.G., Kornfield, K., Hogness, D.S. & Mann, R.S. (1995) Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics, 140, 573-586.
31. Fisher, A.L. & Caudy, M. (1998) Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes and Development, 12, 1931-1940.
32. Frank, R., Zhang, J., Uchida, H., Meyers, S., Hiebert, S.W. & Nimer, S.D. (1995) The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene, 11, 2667-2674.
33. Gamou, T., Kitamura, E., Hosoda, F., Shimizu, K., Shinohara, K., Hayashi, Y., Nagase, T., Yokoyama, Y. & Ohki, M. (1998) The partner gene of AML1 in t(16;21) myeloid malignancies is a novel member of the MTG8 (ETO) family. Blood, 91, 4028-4037.
34. Gelmetti, V., Zhang, J., Fanelli, M., Minucci, S., Pelicci, P.G. & Lazar, M.A. (1998) Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Molecular and Cellular Biology, 18, 7185-7191.
35. Giese, K., Kingsley, C., Kirshner, J.R. & Grosschedl, R. (1995) Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes and Development, 9, 995-1008.
36. Golling, G., Li, L., Pepling, M., Stebbins, M. & Gergen, J.P. (1996) Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt. Molecular and Cellular Biology, 16, 932-942.
37. Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D. & Gilliland, D.G. (1995) Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 92, 4917-4921.
38. Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F.F., Zamir, I., Seiser, C., Lazar, M.A., Minucci, S. & Pelicci, P.G. (1998) Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature, 391, 815-818.
39. Grimwade, D. & Solomon. E. (1997) Characterisation of the PML/RARα rearrangement associated with t(15;17) acute promyelocytic leukaemia. Current Topics in Microbiology and Immunology, 220, 81-112.
40. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, K., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients enrolled into the MRC AML 10 Trial. Blood, 92, 2322-2333.
41. Gross, C.T. & McGinnis, W. (1996) DEAF-1, a novel protein that binds an essential region in a deformed response element. EMBO Journal, 15, 1961-1970.
42. Gu, W. & Roeder, R.G. (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell, 90, 595-606.
43. Guerrasio, A., Rosso, C., Martinelli, G., Lo, C.F., Pampinella, M., Santoro, A., Lanza, C., Allione, B., Resegotti, L. & Saglio, G. (1995) Polyclonal haemopoiesis associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission. British Journal of Haematology., 90, 364-368.
44. Guidez, F., Ivins, S., Zhu, J., Soderstrom, M., Waxman, S. & Zelent, A. (1998) Reduced retinoic acid-sensitivities of nuclear receptor compressor binding to PML-and PLZP-RARα underlie molecular pathogenenesis and treatment of acute promyelocytic leukemia. Blood, 91, 2614-2642.
45. Hagemeijer, A., Garson, O.M. & Kondo, K. (1984) Fourth International Workshop on Chromosomes in leukemia 1982: Translocation (8;21)(q22;q22) in acute nonlymphocytic leukemia. Cancer Genetics and Cytogenetics, 11, 284-287.
46. He, L.Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A. & Pandolfi, P.P. (1998) Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nature Genetics, 18, 126-135.
47. Hernandez-Munain, C. & Krangel, M.S. (1995) c-Myb and core-binding factor/PEBP2 display functional synergy but bind independently to adjacent sites in the T-cell receptor delta enhancer. Molecular and Cellular Biology, 15, 3090-3099 [erratum, 15. 4659].
48. Hong, S.H., David, G., Wong, C.W., Dejean, A. & Privalsky, M.L. (1997) SMRT corepressor interacts with PLZF and with the PML-retinoic add receptor alpha (RARα and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proceedings of the National Academy of Sciences of the United States of America, 94, 9028-9033.
49. Hsiang, Y.H., Spencer, D., Wang, S., Speck, N.A. & Raulet, D.H. (1993) The role of viral enhancer 'core' motif-related sequences in regulating T cell receptor-γ and -δ gene expression. Journal of Immunology, 150, 3905-3916.
50. Hurwitz, C.A., Raimondi, S.C., Head, D., Krance, R., Mirro, J.J., Kalwinsky, D.K., Ayers, G.D. & Behm, F.G (1992) Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood, 80, 3182-3188.
51. Imamura, J., Miyoshi, I. & Koeffler, H.P. (1994) p53 in hematologic malignancies. Blood, 84, 2412-2421.
52. Jurlander, J., Caligiuri, M.A., Ruutu, T., Baer, M.R., Strout, M.P., Oberkircher, A.R., Hoffmann, L., Ball, E.D., Frei-Lahr, D.A., Christiansen, N.P., Block, A.M., Knuutila, S., Herztg, G.P. & Bloomfield, C.D. (1996) Persistence of the AML1/ETO fusion transcript in patients treated wilh allogeneic bone marrow transplantation for t(8;21) leukemia. Blood, 88, 2183-2191.
53. Kalwinsky, D.K., Raimondi, S.C., Schell, M.J., Mirro, J.J., Santana, V.M., Behm, F., Dahl, G.V. & Williams, D. (1990) Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. Journal of Clinical Oncology 8, 75-83.
54. Kanno, T., Kanno, Y., Chen, I.-F. Ogawa, E., Kim, W.-Y. & Ito, Y. (1998) Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor α subunit revealed in the presence of the β subunit. Molecular and Cellular Biology, 18, 2444-2454.
55. Kanno, Y., Kanno, T., Sakakura, C., Bae, S.C. & Ito, Y. (1998) Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor α (CBFα) subunit by the leukemia-related PEBP2/CBFβ-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. Molecular and Cellular Biology, 18, 4252-4261.
56. Kitabayashi, I., Ida, K., Moroboshi, F., Yokoyama, A., Mitsuhashi, N., Shimizu, K., Nomura, N., Hayashi, Y. & Ohki, M. (1998a) The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family. MTGR1. Molecular and Cellular Biology, 18, 846-858.
57. Kitabayashi, I., Yokoyama, A., Shimizu, K. & Ohki, M. (1998b) Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO Journal, 17, 2994-3004.
58. Klampfer, L., Zhang, J., Zelenetz, A.O., Uchida, H. & Nimer, S.D. (1996) The AML1/ETO fusion protein activates transcription of BCL-2. Proceedings of the National Academy of Sciences of the United States of America, 93, 14059-14064.
59. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R.T., Gao, Y.H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S. & Kishimoto, T. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755-764.
60. Kurokawa, M., Tanaka, T., Tanaka, K., Hirano, N., Ogawa, S., Mitani, K., Yazaki, Y. & Hirai, H. (1996a) A conserved cysteine residue in the runt homology domain of AML1 is required for the DNA binding ability and the transforming activity on fibroblasts. Journal of Biological Chemistry, 271, 16870-16876.
61. Kurokawa, M., Tanaka, T., Tanaka, K., Ogawa, S., Mitani, K., Yazaki, Y. & Hirai, H. (1996b) Overexpression of the AML1 protooncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies. Oncogene, 12, 883-892.
62. Lenny, N., Meyers, S. & Hiebert, S.W. (1995) Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene, 11, 1761-1769.
63. Levanon, D., Bernstein, Y., Negreanu, V., Ghozi, M.C., Bar-Am, I., Aloya, R., Goldenberg, D., Lotem, J. & Groner, Y. (1996) A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biology, 15, 175-185.
64. Levanon, D., Goldstein, R.E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., Paroush, Z. & Groner, Y. (1998) Transcriprional repression by AML1 and LEF-1 is mediated by the TLF/Groucho corepressors. Proceedings of the National Academy of Sciences of the United States of America, 95, 11590-11595.
65. Levanon, D., Negreanu, V., Bernstein, Y., Bar-Am, I., Avivi, L. & Groner, Y. (1994) AML1, AML2, and AML3, the, human members of the runt domain gene family: cDNA structure, expression, and chromosomal localization. Genomics, 23, 425-432.
66. Lin, R.J., Nagy, L., Inoue, S., Shao, W., Miller, W.H.J. & Evans, R.M. (1998) Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature, 391, 811-814.
67. Liu, P., Tarle, S.A., Hajra, A., Claxton, D.F., Marlton, P., Freedman, M., Siciliano M.J. & Collins, F.S. (1993) Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science, 261, 1041-1044.
68. Lu, J., Maruyama, M., Satake, M., Bae, S.C., Ogawa, E., Kagoshima, H., Shigesada, K. & Ito, Y. (1995) Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF. Molecular and Cellular Biology, 15, 1651-1661.
69. Lutterbach, B., Sun, D., Schuetz, J. & Hiebert, S.W. (1998a) The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein. Molecular and Cellular Biology, 18, 3604-3611.
70. Lutterbach, B., Westendorf, J.J., Linggi, B., Patten, A., Moniwa, M., Davie, J.R., Huynh, K.D., Bardwell, V.J., Lavinsky, R.M., Rosenfeld, M.G., Glass, C., Seto, E. & Hiebert, S.W. (1998b) ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Molecular and Cellular Biology, 18, 7176-7184.
71. Martinez-Climent, J.A., Lane, N.J., Rubin, C.M., Morgan, E., Johnstone, H.S., Mick, R., Murphy, S.B., Vardiman, J.W., Larson, R.A., Le Beau, M.M. & Rowley, J.D. (1995) Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia, 9, 95-101.
72. Maseki, N., Miyoshi, H., Shimizu, K., Homma, C., Ohki, M., Sakurai, M. & Kaneko, Y. (1993) The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood, 81, 1573-1579.
73. Meyers, S., Downing, J.R. & Hiebert, S.W. (1993) Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Molecular and Cellular Biology, 13, 6336-6345.
74. Meyers, S., Lenny, N. & Hiebert, S.W. (1995) The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Molecular and Cellular Biology, 15, 1974-1982.
75. Mitani, K., Ogawa, S., Tanaka, T., Miyoshi, H., Kurokawa, M., Mano, H., Yazaki, Y., Ohki, M., & Hirai, H. (1994) Generation of the AML1-EV1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia. EMBO Journal, 13, 504-510.
76. Miyamoto, T., Nagafuji, K., Akashi, K., Harada, M., Kyo, T., Akashi, T., Takenaka, K., Mizuno, S., Gondo, H., Okamura, T., Dohy, H. & Niho, Y. (1996) Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood, 87, 4789-4796.
77. Miyoshi, H., Kozu, T., Shimizu, K., Enomoto, K., Maseki, N., Kaneko, Y., Kamada, N. & Ohki, M. (1991) The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO Journal, 12, 2715-2721.
78. Miyoshi, H., Ohira, M., Shimizu, K., Mitani, K., Hirai, H., Imai, T., Yokoyama, K., Soeda, E. & Ohki, M. (1995) Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Research, 23, 2762-2769.
79. Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. & Ohki, M. (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proceedings of the National Academy of Sciences of the United States of America, 88, 10431-10434.
80. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., Lindhout, D., Cole, W.G., Henn, W., Knoll, J.H., Owen, M.J., Mertelsmann, R., Zabel, B.U. & Olsen, B.R. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 89, 773-779.
81. Nisson, P.E., Watkins, P.C. & Sacchi, N. (1992) Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genetics and Cytogenetics, 63, 81-88 [erratum, 1993, 66, 81].
82. North, T., Gu, T.L., Stacy, T., Wang, Q., Howard, L., Binder, M., Marin-Padilla, M. & Speck, N.A. (1998) CBFA2 is required for the emergence of definitive hematopoietic cells from hemogenic endothelium. (Abstract). Blood, 92, (Suppl. 1), 570a.
83. Nuchprayoon, I., Meyers, S., Scott, L.M., Suzow, J., Hiebert. S. & Friedman, A.D. (1994) PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Molecular and Cellular Biology, 14, 5558-5568.
84. Nucifora, G., Begy, C.R., Erickson, P., Drabkin, H.A. & Rowley, J.D. (1993a) The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER I. Proceedings of the National Academy of Sciences of the United States of America, 90, 7784-7788.
85. Nucifora, G., Birn, D.J., Erickson, P., Gao, J., Lebeau, M.M., Drabkin, H.A. & Rowley, J.D. (1993b) Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood, 81, 883-888.
86. Nucifora, G., Birn, D.J., Espinosa, R., Erickson, P., LeBeau, M.M., Roulston, D., McKeithan, T.W., Drabkin, H. & Rowley, J.D. (1993c) Involvement of the AML1 gene in the t(3;21) in therapy-related leukemia and in chronic myeloid leukemia in blast crisis. Blood, 81, 2728-2734.
87. Nucifora, G., Larson, R.A. & Rowley, J.D. (1993d) Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood, 82, 712-715.
88. Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y. & Shigesada, K. (1993a) Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology, 194, 314-331.
89. Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K. & Ito, Y. (1993b) PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proceedings of the National Academy of Sciences of the United States of America, 90, 6859-6863.
90. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. & Nakatani. Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
91. Okuda, T., Cai, Z., Yang, S., Lenny, N., Lyu, C., van Deursen, J.A., Harada, H. & Downing, J.R. (1998) Impression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. Blood, 91, 3134-3143.
92. Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. & Downing, J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
93. Otto, F., Thornell, A.P., Crompton, T., Denzel, A., Gilmour, K.C., Rosewell, I.R., Stamp, G.W., Beddington, R.S., Mundlos, S., Olsen, B.R., Selby, P.H. & Owen, M.J. (1997) Cbfa 1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771.
94. Pazin, M.J. & Kadonaga, J.T. (1997) What's up und down with histone deacetylation and transcription? Cell, 89, 325-328.
95. Petrovick, M.S., Hiebert, S.W., Friedman, A.D., Hetherington, C.J., Tenen, D.G. & Zhang, D.E. (1998) Multiple functional domains of AML1: PU.1 and C/EBPα synergize with different regions of AML1. Molecular and Cellular Biology 18, 3915-3925.
96. Preudhomme, C., Philippe, N., Macintyre, E., Henie, N., Lai, J.L., Jouet, J.P., Cosson, A. & Fenaux, P. (1996) Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: is there a consensus? Leukemia, 10, 186-188.
97. Prosser, H.M., Wotton, D., Gegonne, A., Ghysdael, J., Wang, S., Speck, N.A. & Owen, M.J. (1992) A phorbol ester response element within the human T-cell receptor β-chain enhancer. Proceedings of the National Academy of Sciences of the United States of America, 89, 9934-9938.
98. Redondo, J.M., Pfohl, J.L., Hernandez-Munain, C., Wang, S., Speck, N.A. & Krangel, M.S. (1992) Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor δ and murine leukemia virus enhancers. Molecular and Cellular Biology. 12, 4817-4823.
99. Rhoades, K.L., Hetherington, C.J., Rowley, J.D., Hiebert, S.W., Nucifora, G., Tenen, D.G. & Zhang, D.E. (1996) Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America, 93, 11895-11900.
100. Rhodes, D. (1997) Chromatin structure: the nucleosome core all wrapped up. Nature, 389, 231-233.
101. Rodan, G.A. & Harada, S. (1997) The missing bone. Cell, 89, 677-680.
102. Romana, S.P., Mauchauffe, M., Le Coniat, M., Chumakov, I., Le Paslier, D., Berger, R. & Bernard, O.A. (1995) The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood, 85, 3662-3670.
103. Rowley, J.D. (1982) Identification of the constant chromosome regions involved in human hematologic malignant disease. Science, 216, 749-751.
104. Sakakura, C., Yamaguchi-Iwai, Y., Satake, M., Bae, S.C., Takahashi, A., Ogawa, E., Hagiwara, A., Takahashi, T., Murakami, A. & Makino, K. (1994) Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide. Proceedings of the National Academy of Sciences of the United States of America, 91, 11723-11727.
105. Sasaki, K., Yagi, H., Bronson, R.T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T. & Komori, T. (1996) Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proceedings of the National Academy of Sciences of the United States of America, 93, 12359-12363.
106. Satake, N., Maseki, N., Kozu, T., Sakashita, A., Kobayashi, H., Sakurai, M., Ohki, M. & Kaneko, Y. (1995) Disappearance of AML1-MTG8(ETO) Fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. British Journal of Haematology, 91, 892-898.
107. Saunders, M.J., Brereton, M.L., Adams, J.A., Tobal, K. & Liu, Y.J. (1997) Expression of AML1/MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21). British Journal of Haematology, 99, 921-924.
108. Saunders, M.J., Tobal, K., Keeney, S. & Liu, Y.J. (1996) Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase. Leukemia, 10, 1139-1142.
109. Shoemaker, S.G., Hromas, R. & Kaushansky, K. (1990) Transcriptional regulation of interleukin 3 gene expression in T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 87, 9650-9654.
110. Simeone, A., Daga, A. & Calabi, F. (1995) Expression of runt in the mouse embryo. Developmental Dynamics, 203, 61-70.
111. Sueoka, E., Sueoka, N., Okabe, S., Komori, A., Suganuma, M., Kozu, T. & Fujiki, H. (1998) Tumourigenecity of MTG8, a leukaemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells. British Journal of Haematology, 101, 737-742.
112. Sun, W., Graves, B.J. & Speck, N.A. (1995) Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. Journal of Virology, 69, 4941-4949.
113. Sun, W., O'Connell, M. & Speck, N.A. (1993) Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers. Journal of Virology, 67, 1976-1986.
114. Swirsky, D.M., Lian, Y.S., Matthews, J.G., Flemans, R.J., Rees, J.K. & Hayhoe, F.G. (1984) 8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features. British Journal of Haematology, 56, 199-213.
115. Takahashi, A., Satake, M., Yamaguchi-Iwai, Y., Bae, S.C., Lu, J., Maruyama, M., Zhang, Y.W., Oka, H., Arai, N. & Arai, K. (1995) Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood, 86, 607-616.
116. Tanaka, K., Tanaka, T., Kurokavva, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y. & Hirai, H. (1998) The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1. Blood, 91, 1688-1699.
117. Tanaka, T., Kurokawa, M., Ueki, K., Tanaka, K., Imai, Y., Mitani, K., Okazaki, K., Sagata, N., Yazaki, Y., Shibata, Y., Kadowaki, T. & Hirai, H. (1996) The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability. Molecular and Cellular Biology, 16, 3967-3979.
118. Tanaka, T., Tanaka, K., Ogawa, S., Kurokawa, M., Mitani, K., Nishida, J., Shibata, Y., Yazaki, Y., & Hirai, H. (1995) An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms. EMBO Journal, 14, 341-350.
119. Tanaka, Y., Watanabe, T., Chiba, N., Niki, M., Kuroiwa, Y., Nishihira, T., Satomi, S., Ito, Y. & Satake, M. (1997) The protooncogene product, PEBP2beta/CBFbeta, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures. Oncogene, 15, 677-683.
120. Tobal, K. & Liu, Y.J. (1998) Molecular monitoring of minimal residual disease in acute myeloblastic leukemia with t(8;21) by RT-PCR. Leukemia and Lymphoma, 31, 115-120.
121. Tobal, K. & Yin, J.A. (1996) Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21). Blood, 88, 3704-3709.
122. Wang, J., Hoshino, T., Redner, R.L., Kajigaya, S. & Liu, J.M. (1998) ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proceedings of the National Academy of Sciences of the United States of America, 95, 10860-10865.
123. Wang, J., Wang, M. & Liu, J.M. (1997) Transformation properties of the ETO gene, fusion partner in t(8;21) leukemias. Cancer Research, 57, 2951-2955.
124. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A.H. & Speck, N.A. (1996a) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proceedings of the National Academy of Sciences of the United States of America, 93, 3444-3449.
125. Wang, Q., Stacy, T., Miller, J.D., Lewis, A.F., Gu, T.L., Huang, X., Bushweller, J.H., Bories, J.C., Alt, F.W., Ryan, G., Liu, P.P., Wynshaw-Boris, A., Binder, M., Marin-Padilla, M., Sharpe, A.H. & Speck, N.A. (1996b) The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell, 87, 697-708.
126. Wang, S., Wang, Q., Crute, B.E., Melnikova, I.N., Keller, S.R. & Speck, N.A. (1993) Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Molecular and Cellular Biology 13, 3324-3339.
127. Westendorf, J.J., Yamamoto, C.M., Lenny, N., Downing, J.R., Selsted, M.E. & Hiebert, S.W. (1998) The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Molecular and Cellular Biology, 18, 322-333.
128. Wotton, D., Ghysdael, J., Wang, S., Speck, N.A. & Owen, M.J. (1994) Cooperative binding of Ets-1 and core binding factor to DNA. Molecular and Cellular Biology, 14, 840-850.
129. Yergeau, D.A., Hetherington, C.J., Wang, Q., Zhang, P., Sharpe, A.H., Binder, M., Marin-Padilla, M., Tenen, D.G., Speck, N.A. & Zhang, D.E. (1997) Embryonic lethality und impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genetics, 15, 303-306.
130. Zeng, C., van Wijnen, A.J., Stein, J.L., Meyers, S., Sun, W., Shopland, L., Lawrence, J.B., Penman, S., Lian, J.B., Stein, G.S. & Hiebert, S.W. (1997) Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML-CBFα transcription factors. Proceedings of the National Academy of Sciences of the Unite States of America, 94, 6746-6751.
131. Zhang, D.E., Fujioka, K., Hetherington, C.J., Shapiro, L.H., Chen, H.M., Look, A.T. & Tenen, D.G. (1994) Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Molecular and Cellular Biology, 14, 8085-8095.
132. Zhang, D.E., Hetherington, C.J., Meyers, S., Rhoades, K.L., Larson, C.J., Chen, H.M., Hiebert, S.W. & Tenen, D.G. (1996a) CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Molecular and Cellular Biology, 16, 1231-1240.
133. Zhang, D.E., Hohaus, S., Voso, M.T., Chen, H.M., Smith, L.T., Hetherington, C.J. & Tenen, D.G. (1996b) Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Current Topics in Microbiology and Immunology, 211, 137-147.
134. Zhang, Y.W., Bae, S.C., Huang, G., Fu, Y.X., Lu, J., Ahn, M.Y., Kanno, Y., Kanno, T. & Ito, Y. (1997) A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes With transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells. Molecular and Cellular Biology, 17, 4133-4145.